Search
for
Sort by
Research 961–990 of 1000+
- Real‐world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients
- Role of platelet rich plasma therapy in the treatment of alopecia areata and atrophic acne scars
- Determining meaningful thresholds for evaluating treatment efficacy in patients with alopecia areata
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Chemical bonds and hair behaviour—A review
- The Efficacy of Baricitinib as a Treatment Option for Alopecia, In Terms of Promoting Hair Regrowth and Improving Patient Reported Outcomes
- Review of the 2024 American Academy of Dermatology (AAD) Annual Meeting
- Baricitinib maintains regrowth of hair, eyebrows, and eyelashes over 3 years
- Assessment Of the Relation of Serum Adiponectin Level With Alopecia Areata
- Baricitinib Demonstrates Rapid Action Within Just 2 Months of Treatment in Severe and Unresponsive Alopecia Areata: A Case Report
- Alopecia Areata Treated with Homoeopathic Preparation of Phosphorus: Two Evidence-Based Case Reports
- Real-World Assessment of Disease Characteristics and Clinical Outcomes in Alopecia Areata in a Global Noninterventional Observational Cohort (ADAAGIO)
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- PRP versus intralesional triamcinolone for alopecia areata comparative study
- Hairy tongue associated with the use of baricitinib therapy for ophiasis pattern alopecia areata
- Study of effect of topical mometasone with intralesional platelet-rich plasma versus topical mometasone alone in the treatment of alopecia areata
- Efficacy of Oral Apremilast in The Treatment of Alopecia Areata, at The Tertiary Care Hospital, Karachi
- Effectiveness and safety of baricitinib in patients with moderate‐to‐severe refractory alopecia areata in real world: An open‐label, single‐center study
- Upadacitinib for the treatment of alopecia areata – A case report
- Alopecia areata
- Efficacité à long terme du baricitinib dans le traitement de la pelade : résultats à la semaine 104 des études BRAVE-AA1 et BRAVE-AA2
- Evaluation of the effect of topical calcipotriol versus platelet-rich plasma versus a combination of both on patients with Alopecia Areata
- Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth with Ritlecitinib Through Week 48 in Patients with Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- Alopecia areata: Ritlecitinib generates substantial re-growth of scalp hair
- Deficiency in alopecia areata and responsiveness to vitamin D analogues: A prospective trial
- Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review
- Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2